M.D. Sass Exits Sallie Mae -- Selling Its Entire $33.1 Million Stake

What other to cognize

• M.D. Sass afloat exited SLM -- the involvement present makes up 0% of 13F reportable assets, down from 3.0% successful the erstwhile quarter.

• Top holdings aft the filing include:

  • NASDAQ: HSIC: $93.8 cardinal (7.1% of AUM)

  • NYSE: WMB: $85.4 cardinal (6.5% of AUM)

  • NYSE: AME: $77.6 cardinal (5.9% of AUM)

  • NYSE: CLH: $72.4 cardinal (5.5% of AUM)

  • NYSE: SASS: $66.9 cardinal (5.1% of AUM)

• As of June 8, 2026, SLM shares were trading astatine $22.39 -- down astir 29% implicit the past year, and underperforming the S&P 500 by astir 52 percent points.

Company Overview

Company Snapshot

Sallie Mae is the largest supplier of backstage pupil loans successful the United States, helping students and families concern higher acquisition done a focused suite of banking and lending products.

• Originates and services backstage acquisition loans, with mean loans outstanding of astir $23.3 cardinal arsenic of Q1 2026.

• Offers retail deposit accounts and recognition paper products to enactment the company's backing and liquidity needs.

• Operates arsenic Sallie Mae Bank, a federally chartered slope headquartered successful Newark, Delaware.

What this transaction means for investors

M.D. Sass's implicit exit from SLM is an absorbing move. The presumption antecedently accounted for astir 3% of the fund's full reportable holdings, truthful the determination to merchantability each stock successful a azygous 4th is worthy exploring, adjacent if the rationale isn't spelled retired successful the filing itself.

That said, there's a meaningful disconnect betwixt this organization exit and SLM's astir caller results. The institution delivered a coagulated Q1 2026 -- diluted net per stock came successful astatine $1.54, up from $1.40 a twelvemonth earlier, and backstage acquisition indebtedness originations grew 5% from the prior-year quarter. Management liked what they saw capable to rise their full-year 2026 net guidance to a scope of $3.10 to $3.20 per diluted share.

Still, SLM shares person struggled. The banal is down astir 29% implicit the past twelvemonth -- steep underperformance comparative to the broader marketplace -- and analysts task net to diminution modestly implicit the adjacent fewer years, successful portion owed to uncertainty astir national pupil indebtedness argumentation and longer-term enrollment trends. The banal terms driblet itself whitethorn person accelerated M.D. Sass's decision; the fund's SLM presumption had already mislaid important worth earlier the sale.